BAYZF
Stock Details
BAYZF is Bayer Aktiengesellschaft's stock. Stock exchange Other OTC (Currency USD). Average price in 50 days is 62.34$. Average daily volumn in 3 months 34.8k. Market cap 55.14B
Stock symbol : BAYZF. Exchange : Other OTC. Currency : USD Lastest price : 55.86$. Total volume : 210.00. Market state REGULAR Click reload if you want to check the lastest price on market!!!
Bayer Aktiengesellschaft (BAYZF)
Last Price
55.86$Change
0.00Volume
210.00
| Previous Close | 55.86 |
| Open | 55.86 |
| Day Range | 55.86-55.86 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Volume | 210 |
| Average Volume | 34.8k |
| Market Cap | 55.14B |
| Beta | 1.15 |
| 52 Week Range | 45.99-69.69 |
| Trailing P/E | 16.63 |
| Foward P/E | N/A |
| Dividend (Yield %) | 4.78% |
| Ex-Dividend Date | 2023-05-02 |
Financial Details
Organization
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescr... iption over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases, as well as collaboration with Bicycle Therapeutics to develop bicyclic peptides. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.
Market Cap:
55.14BRevenue:
50.74BTotal Assets:
124.88BTotal Cash:
5.17B
News about "Bayer Aktiengesellschaft"
Bayer Aktiengesellschaft (OTC: BAYR.Y)
Source from : The Motley Fool - 2 days ago
Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments ...See details»
Bayer Aktiengesellschaft 2023 Q1 - Results - Earnings Call Presentation
Source from : Seeking Alpha - 22 days ago
Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site ...See details»
Bayer AG ADR
Source from : Wall Street Journal - 6 days ago
No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...See details»
Can Bayer Aktiengesellschaft (ETR:BAYN) Improve Its Returns?
Source from : Yahoo News - 21 days ago
To keep the lesson grounded in practicality, we'll use ROE to better understand Bayer Aktiengesellschaft (ETR:BAYN). Return on equity or ROE is a key measure used to assess how efficiently a company's ...See details»
Client Profile: Bayer AG
Source from : OpenSecrets.org - 1 year ago
Bayer Corp $6,070,000 Kellie Adesina No Revolving Door Profiles Non Former Members of Congress Bayer Corp $6,070,000 Julie Corcoran No Revolving Door Profiles Non Former Members of Congress Bayer Corp ...See details»
Bayer AG Non-GAAP EPS of €2.95, revenue of €14.39B; targets outlook at lower end of guidance
Source from : Seeking Alpha - 28 days ago
Bayer AG press release (OTCPK:BAYZF): Q1 Non-GAAP EPS of €2.95. Revenue of €14.39B (-1.7% Y/Y). Group EBITDA before special items declined by 14.9% to €4,471 million. EBIT of the Bayer Group ...See details»
Continuous Glucose Monitoring Devices Market Size 2023 to 2033 | By Novo Nordisk, Bayer AG, Dexcom, Qualcomm
Source from : PharmiWeb - 15 hours ago
The global sales of Continuous Glucose Monitoring Device Market in 2023 are anticipated to be US$ 5.5 Billion, according to Future Market Insights’ recently published Global Continuous Glucose ...See details»
BAYRY - Bayer Aktiengesellschaft
Source from : Yahoo Finance - 1 month ago
(Reuters) -The U.S. Supreme Court on Monday declined to hear a dispute involving a lawsuit against Bayer AG's Monsanto Co that could rein in a common form of settlement in class action cases under ...See details»
BAYN.DE - Bayer Aktiengesellschaft
Source from : Yahoo Finance - 1 year ago
AstraZeneca's (AZN) Ultomiris gets approval for a new rare disease indication in the EU. It looks like Bayer Aktiengesellschaft ( ETR:BAYN ) is about to go ex-dividend in the next four days. The ...See details»
BAYZF - Bayer Aktiengesellschaft
Source from : Yahoo Finance - 4 month ago
The U.S. Supreme Court on Monday declined to hear a dispute involving a lawsuit against Bayer AG's Monsanto Co that could rein in a common form of settlement in class action cases under which money is ...See details»
BAYN.F - Bayer Aktiengesellschaft
Source from : Yahoo Finance - 1 month ago
(Reuters) -The U.S. Supreme Court on Monday declined to hear a dispute involving a lawsuit against Bayer AG's Monsanto Co that could rein in a common form of settlement in class action cases under ...See details»
Bayer AG (BAYN.DU)
Source from : Yahoo Finance - 3 month ago
However, sales of the lead drug Eylea declined yet again. Simply Wall St. Should Income Investors Look At Bayer Aktiengesellschaft (ETR:BAYN) Before Its Ex-Dividend? It looks like Bayer ...See details»
Can Bayer Aktiengesellschaft (ETR:BAYN) Improve Its Returns?
Source from : Yahoo Finance - 21 days ago
To keep the lesson grounded in practicality, we'll use ROE to better understand Bayer Aktiengesellschaft (ETR:BAYN). Return on equity or ROE is a key measure used to assess how efficiently a ...See details»
bayer ag
Source from : Fox Business - 2 years ago
Bayer AG has agreed to pay a $40 million settlement stemming from two whistleblower lawsuits filed in 2005 and 2006 over the company's alleged use of kickbacks and false statements. A Los Angeles ...See details»